NCBiotech News

Hernan Navarro, Ph.D., retired chief scientist for RTI International’s Center for Drug Discovery, has returned to the workplace to direct the Biomedical Research Institute and Technology Enterprise (BRITE) at North Carolina Central University in Durham. 

Raleigh-based Eva Garland Consulting (EGC) is on the prestigious Inc. 5000 list of the country’s fastest-growing private companies.

North Carolina is home to six of the top 10 community colleges in the nation, according to SmartAsset, an online site aimed at helping people make smart financial decisions.

Funding from the North Carolina Biotechnology Center has enabled doctors in Western N.C. to use genetic testing to prescribe more-effective medicines for their patients. It’s part of a larger center-led effort to promote the statewide growth and development of precision health.

BARDA's Division of Research, Innovation and Ventures, or DRIVe, has simplified the process companies and researchers can use to apply for grants to fund disruptive solutions to health security threats.

When URO-1 Medical of Winston-Salem needed help commercializing its new medical device, the startup tapped a neighbor: Novex Innovations, a contract development and manufacturing organization that helps life science companies get their products to market quickly and inexpensively. 

Just three weeks after scuttling plans to merge with a Pennsylvania company and move there, publicly traded Durham biotechnology company BioCryst Pharmaceuticals is selling up to $57.5 million in stock in an underwritten public offering.

BASF, a German conglomerate with global reach in chemical, pharmaceutical and agricultural science, has closed its huge $9 billion purchase of businesses and assets from Bayer, moving four facilities and more than 360 former Bayer employees into the fold of BASF’s Research Triangle Park operations.

United Therapeutics Corp. has received approval from the U.S. Food and Drug Administration to begin marketing and selling an implantable system for delivering Remodulin, its treatment for pulmonary arterial hypertension (PAH), or high blood pressure in the lungs.

The North Carolina Biotechnology Center has named Mary Beth Thomas, Ph.D., to the position of senior vice president, science and business development.

The North Carolina Biotechnology Center awarded 11 grants and loans totaling $2,125,000 to universities, bioscience companies and other organizations in the fourth quarter of fiscal year 2018 ending June 30.

Morrisville-based drug development company Liquidia Technologies shares began trading on the Nasdaq Capital Market yesterday, July 26, under the ticker symbol “LQDA,” opening at $12.45 and closing at $11.10.

As founder, president and CEO of Durham-based Eppin Pharma, Michael O’Rand is pursuing a contraceptive that he says would be “a brand new choice for men and also very helpful for family planning, for men and women.”

Early- to late-stage life science companies have until July 31 to submit applications to present at the 2018 Southeast BIO Investor & Partnering Forum to be held in Atlanta November 13-14.

Durham-based hearing technology company MED-EL USA has been granted a U.S. Food and Drug Administration clearance to market its BONEBRIDGE bone conduction hearing implant system in the United States.